Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trials

INTRODUCTION: The existing medications approved for treatment of primary osteoporosis can be divided into antiresorptive drugs and anabolic drugs. According to the mechanisms of action, the combined therapy may produce a synergistic effect on bone mineral density (BMD) compared with monotherapy, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Shenghan, Lv, Houchen, Chen, Yuxiang, Zhang, Licheng, Tang, Peifu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128987/
https://www.ncbi.nlm.nih.gov/pubmed/28186942
http://dx.doi.org/10.1136/bmjopen-2016-012802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128987/
https://www.ncbi.nlm.nih.gov/pubmed/28186942
http://dx.doi.org/10.1136/bmjopen-2016-012802

Ejemplares similares